Skip to main content
. 2021 Aug 18;112(10):4393–4403. doi: 10.1111/cas.15084

FIGURE 3.

FIGURE 3

Fusion detection sensitivities of the cfRNA‐based and cfDNA‐based assays for patients who were untreated or with PD. The sensitivities of the cfRNA‐based and cfDNA‐based assays were compared with the use of 9 plasma samples collected from 9 patients who were chemotherapy‐naïve or diagnosed with PD (cases 3‐11). The same plasma was used for both assays